A Novel SET Antagonist (OP449) Is Cytotoxic to CML Cells, Including the Highly-Resistant BCR-ABL(T315I) Mutant, and Demonstrates Enhanced Efficacy in Combination with ABL Tyrosine Kinase Inhibitors

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Agarwal, A; MacKenzie, R; Oddo, J; Vitek, MP; Christensen, DJ; Druker, BJ

Published Date

  • November 18, 2011

Published In

Volume / Issue

  • 118 / 21

Start / End Page

  • 1603 - 1604

Published By

Pages

  • 2

International Standard Serial Number (ISSN)

  • 0006-4971

Conference Name

  • 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis

Conference Location

  • San Diego, CA

Conference Start Date

  • December 10, 2011

Conference End Date

  • December 13, 2011